Cyteir Therapeutics Inc Free Cash Flow to Firm (FCFF) 5 year CAGR is NA for the Trailing 12 Months (TTM) ending June 30, 2023. Free Cash Flow to Firm represents the cash flow available to all capital providers, including both equity and debt holders. It considers the tax shield effect of interest expense. This ratio indicates the company's ability to generate cash flow available to all stakeholders, including interest payments to debt holders and returns to equity shareholders. CAGR, or the Compound Annual Growth Rate, quantifies the mean annual growth rate of an investment or financial metric over a specified time span, considering the influence of compounding. It is instrumental in determining the true annualized return on an investment.